Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression

Journal of Psychopharmacology

Volumn 12, Issue 3 SUPPL. B, 1998, Pages

  Amsterdam, Jay D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adrenocortical dopamine; Confounding; Endogenous; Hypothalamic; Pituitary; Psychomotor disturbances

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGING; ARTICLE; CLINICAL TRIAL; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG EFFICACY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MELANCHOLIA; META ANALYSIS; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER;

EID: 0031732769     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881198012003061     Document Type: Article

References (109)

1. Akil M, Schwartz JA, Dutchak D, et al. (1991) The psychiatric presentations of Wilson's disease, J Neuropsychiatry Clin Neurosci 3: 377-382.
2. Albert ML, Feldman RG, Willis AL (1974) The 'subcortical dementia' of progressive supranuclear plasy. J Neurol Neurosurg Psychiatry 37: 121-130.
3. Alexander G E, DeLong M R, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 9: 357-381.
4. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. (revised). Washington, DC: American Psychiatric Association.
5. Amsterdam J D, Maislin G, Winokur A, Gold P (1987) Pituitary and adrenocortical response to ovine corticotropn-releasing hormone in depressed patients and healthy volunteers. Arch Gen Psychiatry 44: 775-781.
6. Amsterdam JD, Maislin G, Winokur A, Phillips J, Berwish N, Gold P (1989a) The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness. Psychoneuroendocrinology 14: 43-62.
7. Amsterdam JD, Maislin G, Berwish N, Phillips J, Winokur A (1989b) Enhanced adrenocortical sensitivity to submaximal doses of cosyntropin (ACTH) in depressed patients. Arch Gen Psychiatry 46: 550-558.
8. Austin M P, Ross M, Murray C, et al. (1992) Cognitive function in major depression. J Affect Disord 25: 21-30.
9. Avery D, Silverman J (1984) Psychomotor retardation and agitation in depression: relationship to age, sex and response to treatment. J Affect Disord 7: 67-76.
10. Baldwin RC (1993) Late-life depression and structural brain changes. A review of recent magnetic resonance imaging research. Int J Geriatr Psychiatry 8: 115-123.
11. Baxter LR, Phelps ME, Mazziotta JC, et al. (1989) Cerebral metabolic rates for glucose in mood disorders studied with positron emission tomography with FDG. Arch Gen Psychiatry 42: 441-142.
12. Beasley C M Jr, Holman S L, Potvin J H (1993) Fluoxetine compared with imipramine in the treatment of inpatient depression: a multicenter trial. Ann Clin Psychiatry 5: 199-208.
13. Bennie E H, Mullin J M, Martindale J J (1995) A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry 56: 29-237.
14. Bisserbe J-C, Lane R, Wiseman R (1996) Predictors of response to SSRIs in patients with major depression. Eur Neuropsychopharmacol 6 (Suppl. 3): 122.
15. Bolden-Watson C, Richelson E (1993) Blockade by newly developed antidepressants if biogenic amine uptake into rat brain synaptosomes. Life Sci 52: 1023-1029.
16. Brown AS, Gershon S (1993) Dopamine and depression. J Neural Trans 91: 75-109.
17. Brown R, Sweeney J, Loutsch E, et al. (1984) Involutional melancholia revisited. Am J Psychiatry 141: 24-28.
18. Buchsbaum M S, Wu J, DeLisi L E, et al. (1986) Frontal cortex and basal ganglia metabolic rates assessed by PET with F-2 deoxyglucose in affective illness. J Affect Disord 10: 137-152.
19. Calloway S P, Dolan J, Fonagy P, et al. (1984) Endocrine changes and clinical profiles in depression: I. The dexamethasone suppression test. Psychol Med 14: 749-758.
20. Carney MWP, Roth M, Garside R F (1965) The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 111: 659-674.
21. Carroll BJ, Feinberg M, Greden J F, et al. (1981) A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Arch Gen Psychiatry 38: 15-22.
22. Clerc G E, Ruimy P, Verdeau-Palles J (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. Int Clin Psychopharmacol 9: 139-143.
23. Coffey C E, Figiel G S, Djang W R, et al. (1988) Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry 24: 143-161.
24. Coffey C E, Figiel G S, Djang W R, et al. (1989) White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomical correlates in the depressed elderly. J Neuropsychiatry Clin Neurosci 1: 135-144.
25. Coffey CE, Figiel GS, Djang WT, Weiner RD (1990) Subcortical hyperintesity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 147: 187-189.
26. Coffey CE, Wilkinson WE, Parashos SA (1992) Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 42: 527-536.
27. Coffey DJ, Jenkyn LR, Coffey A K, Wells BB (1994) Sertraline vs amitriptyline vs placebo: effects on cognitive and motor functioning in the elderly. Neuropsychopharmacology 10: 222S.
28. Cummings JL (1992) Depression and Parkinson's disease: a review. Am J Psychiatry 149: 443-454.
29. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 90: 131-138.
30. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 18: 289-299.
31. Davidson J, Lipper S, Zung W W K, et al. (1984) Validation of four definitions of melancholia by the dexamethasone suppression test. Am J Psychiatry 141: 1220-1223.
32. de Jonghe F, Swinkels J (1997) Selective serotonin reuptake inhibitors. Relevance or differences in their pharmacological and clinical profiles. CNS Drugs 7: 452-467.
33. Doogan DP, Langdon CJ (1994) A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice. Int Clin Psychopharmacol 9: 95-100.
34. Dupont R M, Jernigan T L, Gillin J C, et al. (1987) Subcortical signal hyperintensities in bipolar patients detected by MRI. Psychiatry Res 21: 357-358.
35. Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum J F (1997) Major depression subtypes and treatment responses. Biol Psychiatry 42: 568-576.
36. Fabre L F, Abuzzahab F S, Amin M, Claghorn J L, Mendels J, Petrie WM, Dube S, Small JG (1995) Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo- Biol Psychiatry 38: 592-602.
37. Feighner J P, Cohn J B, Fabre L F Jr, et al. (1993) A study comparing paroxetine, placebo, and imipramine in depressed patients. J Affect Disord 28: 71-79.
38. Figiel G S, Krishnan K R R, Rao V, et al. (1991) Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci 3: 18-21.
39. Gatz C, Scott J (1972) Age and measurement of mental health. J Health Soc Behav 13: 55-67.
40. Gotham AM, Brown RG, Marsden CD (1988) 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 111: 299-321.
41. Harrell LE, Duvall E, Folks DG, et al. (1991) The relationship of high-intensity signals on magnetic resonance images to cognitive and psvchiatric state in Alzheimer's disease. Arch Neurol 48: 1136-1140.
42. Hegerl U, Gallinet J, Moeller H-J (1997) Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression. Poster presented at the 10th Meeting of the European College of Neuropsychopharmacology, Vienna.
43. Heiligenstein JH, Tollefson GD, Paries DE (1993) A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia. Int Clin Psychopharmacol 8: 247-251.
44. Heiligenstein JH, Tollefson GD, Faries DE (1994) Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo. J Affect Disord 30: 163-173.
45. Hickie I (1996) Validity of the CORE: II. Neuropsyehological tests. In Parker G, Hadzi-Pavlovic D (eds), Melancholia: a disorder of movement and mood. Cambridge University Press, Cambridge, pp. 149-159.
46. Hickie I, Mason C, Parker G, Brodaty H (1996) Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry 169: 68-74.
47. Hickie I, Scott E, Mitchell P, et al. (1995) Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37: 151-160.
48. Hindmarch I, Shillingford J, Shillingford C (1990) The effects of sertraline on psychomotor performance in elderly volunteers. J Clin Psychiatry 51 (Suppl. 12B): 34-36.
49. Husain MM, McDonald WM, Doraiswamy PM, Figiel GS, Na C, Escalone P R, Boyko O B, Nemeroff C B, Krishnan KRR (1992) A magnetic resonance imaging of the caudate nucleus in depression. Arch Gen Psychiatry 49: 553-557.
50. Hyttel J (1993) Comparative pharmacology of selective serotonin reuptake inhibitors (SSRIs). Nord J Psychiatry 47 (Suppl. 30): 5-20.
51. Jeste DV, Karson CN, Wyatt RJ (1984) Movement disorders and psychopathology in neuropsychiatrie movement disorders. In Jeste DV, Wyatt RJ (eds), Movement disorders and psychopathology in neuropsychiatrie movement disorders. American Psychiatric Press Inc, Washington DC.
52. Kasahara H, Tanno M, Yamada H, et al. (1993) MRI study of the brain in aged volunteers: T2 high signal intensity lesions and high cortical function. Japan J Geriatrics 30: 892-900.
53. Kasper S, Möller H-J, Montgomery SA, Zondag E (1995) Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine vs. imipramine. Int Clin Psychopharmacol 9 (Suppl. 4): 3-12.
54. Keller M B (1988) Diagnostic issues and clinical course of unipolar illness. Review of psychiatry. American Psychiatric Press, Washington, DC, pp. 188-212.
55. Kendler KS (1997) The disgnostic validity of melancholic major depression in a population-based sample of female twins. Arch Gen Psychiatry 54: 299-304.
56. Kraepelin J (1893) Psychiatric (4th edn). Barth, Leipzig.
57. Krishnan KRR, Goli V, Ellinwood E H, et al. (1988) Leukoencephalopathy in patients diagnosed as major depression. Biol Psychiatry 23: 519-522.
58. Krishnan KRR, McDonald WM, Escalone PR, et al. (1932) Magnetic resonance imaging of the caudate nuclei in depression: preliminary observations. Arch Gen Psychiatry 49: 553-557.
59. Krishnan K R (1993) Neuroanatomic substrates of depression in the elderly. J Geriatr Psychiatry Neurol 6: 39-58.
60. Lanczik M, Beckmann H (1991) Historical aspects of affective disorders. In Feighner J P, Boyer W F (eds),The diagnosis of depression. John Wiley & Sons, Chichester, pp. 1-16.
61. Lapierre YD (1991) Controlling acute episodes of depression. Int Clin Psychopharmacol 6: 23-35.
62. Latimer PR, Ravindran AV, Bernatchez J-P, et al. (1996) A six month comparison of toleration and efficacy of sertraline and fluoxetine treatment of major depression. Eur Neuropsychopharmacol 6 (Suppl. 3): 124.
63. Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P (1996) Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 34: 241-251.
64. Lepine JP, Wiseman R, Zhu G (1997) A double-blind efficacy and safety study of sertraline and clomipramine in severe major depression [abstract]. Biol Psychiatry 42: 24-95.
65. Lesser IM, Miller BL, Boone K B (1991) Brain injury and cognitive function in late-onset psychotic depression, J Neuropsychiatry Clin Neurosci 3: 33-40.
66. Malt U F, Robak O H, Madsbu H-P, et al. (1995) Practical aspects of long-term treatment. Eur Neuropsychopharmacol 5 (Suppl. 3): 288-289.
67. Matsubayashi K, Shimada K, Kawamoto A, Ozama T (1992) Incidental brain lesions on magnetic resonance imaging and neurobehavioral functions in apparently healthy elderly. Stroke 23: 175-180.
68. Mayeux R (1990) Depression in the patient with Parkinson's disease. J Clin Psychiatry 51 (Suppl. 7): 20-23.
69. Mayeux R, Sten Y, Rosen J, Leventhal J (1981) Depression. Intellectual impairment and Parkinson's disease. Neurology 31: 645-650.
70. Mendez M F, Adams N L, Lewandoski K S (1989) Neurobehavioral changes associated with caudate lesions. Neurology 39: 349-354.
71. McDonald WM, Krishnan KRR, Doraiswamy PM, Blazer DG (1991) Occurrence of subcortical hyperintensities in elderly subjects with mania. Psychiatry Res Neuroimaging 40: 211-220.
72. McEntee W, Ko G, Richter E (1996) Sertraline and nortriptyline: heart rate, cognitive improvements and quality of life in depressed elderly. Eur Neuropsychopharmacol 6 (Suppl. 3): 36.
73. McEntee WJ, Mair RG, Langlais PJ (1987) Neurochemical specificity of learning: dopamine and motor learning. Yale J Biol Med 60: 187-193.
74. Mitchell P (1996) Validity of CORE: I. A neuroendocrinology strategy. In Parker G, Hadzi-Pavlovic D (eds), Melancholia. Cambridge: Cambridge University Press, pp. 138-148.
75. Montgomery S A, Henry J, McDonald G, et al. (1994) Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates. Int Clin Psychopharmacol 9: 47-53.
76. Muth EA, Hasking JT, Moyer JA, et al. (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45, 030, and ethyl cyclohexanol derivative. Biochem Pharmacol 35: 4493-4497.
77. Newhouse PA, Ko G, Richter E M (1996) Comparison of sertraline and fluoxetine in depressed geriatric out-patients: plasma levels and efficacy. Eur Neuropsychopharmacol 6(Suppl. 3): 35.
78. Olie JP, Gunn KP, Katz E (1997) A double-blind placebo-controlled multicentre study of sertraline on the acute and continuation treatment of major depression. Eur Psychiatry 12: 34-41.
79. Parker G, Brotchie H (1992) Psychomotor change as a feature of depression disorders: an historical overview. Aust NZ J Psychiatry 26: 146-155.
80. Parker G, Hadzi-Pavlovic D, eds (1996) Melancholia: a disorder of movement and mood. Cambridge University Press, Cambridge.
81. Parker G, Hadzi-Pavlovic D, Boyce P, et al. (1990) Classifying depression by mental state signs. Br J Psychiatry 157: 55-65.
82. Parker G, Boyce P, Mitchell P, et al. (1994) Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry 164: 316-326.
83. Parker G, Hadzi-Pavlovic D, Austin M-P, et al. (1995) Sub-typing depression. I. Is psychomotor disturbance necessary and sufficient to the definition of melancholia. Psychol Med 25: 815-823.
84. Perry PJ (1996) Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 39-1-6.
85. Philipp M, Maier W, Holsboer F (1986) Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach. Psychoneuroendocrinology 11: 449-507.
86. Prien R F (1988) Somatic treatment of unipolar depressive disorder. Review of Psychiatry. American Psychiatric Press, Washington, DC, pp. 213-234.
87. Rabins PV, Pearlson GD, Aylward E (1991) Cortical magnetic resonance imaging changes in elderly patients with major depression. Am J Psychiatry 148: 617-620.
88. Reimherr F W, Chouinard G, Cohn C K, et at. (1990) Antidepressant efficacy of sertraline: a double-blind, placebo and amitriptylinecontrolled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 51 (Suppl. 12B): 18-27.
89. Ribiero SCM, Tandon R, Grunhaus L, et al. (1993) The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150: 1618-1629.
90. Rogers D (1993) Functional depression viewed as neurologic disease. In Starkstein SE, Robinson RG (eds), Depression in neurologic disease. Johns Hopkins University Press, Baltimore, pp. 13-27.
91. Rogers D, Lees AJ, Smith E, et al (1987) Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: an experimental study. Brain 110: 761-766.
92. Roose SP, Glassman AH, Attia E, Woodring S (1994) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151: 1735-1739.
93. Roth M (1978) Classification of affective disorders. Pharmakopsychiatics 11: 27-42.
94. Rush A J, Weissenburger J E (1994) Melancholic symptom features and DSM-IV Am J Psychiatry 151: 489-498.
95. Salloway S, Malloy P, Kohn R, et al. (1996) MRI and neuropsychological differences in early and late-life-onset geriatric depression. Neurology 46: 1567-1574.
96. Schneider LS, Reynolds CF, Lebowtz BD (1994) Diagnosis and treatment of depression in late-life. Am Psychiatric Press, Washington, DC.
97. Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria. New York State Psychiatric Institute, New York.
98. Starkstein SE, Robinson RG, Price TR (1987) Comparison of cortical and subcortical lesions in the production of post stroke mood disorder. Brain 110: 1045-1059.
99. Starkstein SE, Preziosi TJ, et al. (1989) Depression and cognitive impairment in Parkinson's disease. Brain 112: 1141-1153.
100. Strange PG (1993) Dopamine receptros in the basal ganglia: relevance to Parkinson's disease. Movement Disord 8: 263-270.
101. Stuppaeck CH, Geretsegger C, Whitworth A B, et al. (1994) A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. J Clin Psychopharmacol 14: 241-246.
102. Tignol J, Stoker M J, Dunbar G C (1992) Laroxetine in the treatment of melancholic and severe depression. Int Clin Psychopharmacol 7: 91-94.
103. Tolosa ES, Lai C (1979) Meige disease: striatal dopaminergic preponderance. Neurology 23: 1126-1130.
104. Trautner RJ, Cummings J L, Read S L, Benson D F (1988) Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry 145: 350-353.
105. Winokur G, Behan D, Schlesser M (1980) Clinical and biological aspects of depression in the elderly. In Cole J O, Barrett J E (eds), Psychopathology in the aged. Raven Press, New York, 1980.
106. Ylikoski R, Ylikoski A, Erkinjuntti T, et al. (1993) White matter changes in healthy elderly persons correlated with attention and speed of mental processing. Arch Neurol 50: 818-824.
107. Zanardi R, Franchini L, Gasperini M, Perez J, Smeraldi E (1996) Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 153: 1631-1633.
108. Zimmerman M, Black DW, Coryell W (1989) Diagnostic criteria for melancholia: the comparative validity of DSM-III and DSM-III-R. Arch Gen Psychiatry 46: 361-368.
109. Zimmerman M, Coryell W, Pfohl B (1986) The validity of the dexamethasone suppression test as a marker for endogenous depression. Arch Gen Psychiatry 43: 347-355.